Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sox6
|
ENSMUSG00000051910.7 | Sox6 |
Sox9
|
ENSMUSG00000000567.5 | Sox9 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Sox6 | chr7_115568359_115569272 | 29081 | 0.255505 | 0.78 | 1.6e-13 | Click! |
Sox6 | chr7_115568205_115568356 | 29616 | 0.253699 | 0.54 | 6.8e-06 | Click! |
Sox6 | chr7_115823042_115823788 | 1295 | 0.601213 | 0.53 | 1.2e-05 | Click! |
Sox6 | chr7_115823790_115824046 | 792 | 0.765906 | 0.51 | 3.1e-05 | Click! |
Sox6 | chr7_115513829_115514113 | 83925 | 0.106762 | 0.46 | 2.5e-04 | Click! |
Sox9 | chr11_112784278_112785462 | 2646 | 0.240445 | 0.42 | 8.6e-04 | Click! |
Sox9 | chr11_112783635_112784177 | 1682 | 0.306844 | 0.32 | 1.2e-02 | Click! |
Sox9 | chr11_112786321_112786760 | 4316 | 0.201561 | 0.32 | 1.4e-02 | Click! |
Sox9 | chr11_112787051_112787394 | 4998 | 0.194370 | 0.31 | 1.6e-02 | Click! |
Sox9 | chr11_112782257_112783134 | 471 | 0.600059 | 0.30 | 1.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_6883618_6884699 | 10.19 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr9_52148115_52149635 | 9.91 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chrX_152643367_152644550 | 9.76 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chrX_143930842_143933141 | 8.11 |
Dcx |
doublecortin |
1059 |
0.64 |
chr12_29528407_29529244 | 7.88 |
Myt1l |
myelin transcription factor 1-like |
424 |
0.85 |
chr13_83732205_83734272 | 7.50 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr12_29529828_29531185 | 7.10 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr9_41378412_41379411 | 6.79 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2350 |
0.27 |
chr5_115431565_115432258 | 6.40 |
Msi1 |
musashi RNA-binding protein 1 |
1306 |
0.22 |
chr9_52145956_52147029 | 6.15 |
Zc3h12c |
zinc finger CCCH type containing 12C |
21619 |
0.17 |
chr4_22485441_22485749 | 6.07 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
2771 |
0.23 |
chr6_16995401_16995946 | 5.93 |
Gm15473 |
predicted gene 15473 |
69323 |
0.1 |
chr13_34126566_34127191 | 5.90 |
Tubb2b |
tubulin, beta 2B class IIB |
3476 |
0.13 |
chr1_9601164_9602408 | 5.87 |
Vxn |
vexin |
587 |
0.67 |
chr3_8509825_8511666 | 5.56 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr14_122477033_122477655 | 5.38 |
Zic2 |
zinc finger protein of the cerebellum 2 |
756 |
0.48 |
chr2_151966993_151968089 | 5.34 |
Mir1953 |
microRNA 1953 |
76 |
0.96 |
chrX_23284413_23285126 | 5.33 |
Klhl13 |
kelch-like 13 |
60 |
0.99 |
chr16_77645925_77646470 | 5.28 |
Mir125b-2 |
microRNA 125b-2 |
76 |
0.58 |
chr6_112943851_112944495 | 5.12 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
2581 |
0.19 |
chr3_17790150_17790808 | 4.88 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
522 |
0.77 |
chr4_22481292_22481918 | 4.86 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
6761 |
0.17 |
chrX_58032839_58033176 | 4.77 |
Zic3 |
zinc finger protein of the cerebellum 3 |
1997 |
0.41 |
chr15_98983254_98984205 | 4.65 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
102 |
0.93 |
chr3_34651759_34652037 | 4.63 |
Sox2 |
SRY (sex determining region Y)-box 2 |
1493 |
0.26 |
chrX_134405492_134405850 | 4.60 |
Drp2 |
dystrophin related protein 2 |
869 |
0.59 |
chr9_36821403_36822795 | 4.57 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
235 |
0.9 |
chr2_6884711_6884884 | 4.55 |
Celf2 |
CUGBP, Elav-like family member 2 |
95 |
0.88 |
chrX_166346283_166346827 | 4.52 |
Gpm6b |
glycoprotein m6b |
1713 |
0.43 |
chr8_45507516_45508498 | 4.50 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
89 |
0.97 |
chr13_44842150_44842855 | 4.46 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
1719 |
0.39 |
chr10_111249619_111250191 | 4.44 |
Osbpl8 |
oxysterol binding protein-like 8 |
1837 |
0.35 |
chr2_181764652_181765649 | 4.43 |
Myt1 |
myelin transcription factor 1 |
1818 |
0.27 |
chr18_72347538_72348154 | 4.41 |
Dcc |
deleted in colorectal carcinoma |
3171 |
0.38 |
chr4_24429901_24430719 | 4.40 |
Gm27243 |
predicted gene 27243 |
580 |
0.79 |
chr14_108912235_108913525 | 4.25 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
1278 |
0.64 |
chr7_144238658_144240098 | 4.24 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
653 |
0.8 |
chr15_98986992_98987777 | 4.24 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
1490 |
0.22 |
chr13_97248475_97250229 | 4.23 |
Enc1 |
ectodermal-neural cortex 1 |
8247 |
0.17 |
chr13_97243599_97244237 | 4.21 |
Enc1 |
ectodermal-neural cortex 1 |
2813 |
0.23 |
chr18_35212708_35213458 | 4.16 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1847 |
0.28 |
chr6_17750183_17750783 | 4.16 |
St7 |
suppression of tumorigenicity 7 |
1091 |
0.38 |
chr12_72234504_72235243 | 4.10 |
Rtn1 |
reticulon 1 |
866 |
0.66 |
chr13_84056577_84057434 | 4.09 |
Gm17750 |
predicted gene, 17750 |
7767 |
0.22 |
chr3_34562856_34563429 | 4.04 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
2750 |
0.22 |
chr5_120145860_120146241 | 4.04 |
Gm10390 |
predicted gene 10390 |
6787 |
0.2 |
chr19_22447648_22448999 | 4.01 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
91 |
0.63 |
chr1_135583494_135584229 | 3.98 |
Gm4793 |
predicted gene 4793 |
912 |
0.48 |
chr12_117157079_117158175 | 3.95 |
Gm10421 |
predicted gene 10421 |
5976 |
0.31 |
chr4_122998794_122999794 | 3.94 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
45 |
0.97 |
chr6_93911862_93913573 | 3.87 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr1_6734529_6735444 | 3.81 |
St18 |
suppression of tumorigenicity 18 |
116 |
0.98 |
chr3_17783692_17784517 | 3.80 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
5817 |
0.2 |
chr14_66344363_66345813 | 3.75 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr10_92164912_92165194 | 3.74 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
82 |
0.98 |
chr9_108824114_108825614 | 3.70 |
Gm35025 |
predicted gene, 35025 |
3 |
0.87 |
chrX_58033180_58034063 | 3.65 |
Zic3 |
zinc finger protein of the cerebellum 3 |
2611 |
0.36 |
chr18_77560987_77561705 | 3.60 |
Rnf165 |
ring finger protein 165 |
3263 |
0.29 |
chr9_91366433_91367646 | 3.58 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1229 |
0.26 |
chr1_81079064_81079824 | 3.58 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
1861 |
0.49 |
chr16_77598670_77599917 | 3.51 |
Mir99a |
microRNA 99a |
357 |
0.44 |
chr17_8802429_8803035 | 3.50 |
Pde10a |
phosphodiesterase 10A |
296 |
0.93 |
chr7_128690432_128691249 | 3.48 |
Gm16044 |
predicted gene 16044 |
1849 |
0.17 |
chr2_49619321_49620607 | 3.42 |
Kif5c |
kinesin family member 5C |
666 |
0.78 |
chr2_158606690_158608449 | 3.41 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr6_116107038_116107576 | 3.36 |
Gm20404 |
predicted gene 20404 |
343 |
0.63 |
chr14_52003695_52004200 | 3.34 |
Arhgef40 |
Rho guanine nucleotide exchange factor (GEF) 40 |
135 |
0.9 |
chr4_33926104_33927188 | 3.28 |
Cnr1 |
cannabinoid receptor 1 (brain) |
444 |
0.88 |
chr2_79452354_79452909 | 3.27 |
Neurod1 |
neurogenic differentiation 1 |
4120 |
0.24 |
chr7_16948034_16948663 | 3.26 |
Pnmal2 |
PNMA-like 2 |
3666 |
0.11 |
chr5_107498769_107499247 | 3.26 |
Btbd8 |
BTB (POZ) domain containing 8 |
1229 |
0.33 |
chr2_137808388_137808680 | 3.26 |
Gm14062 |
predicted gene 14062 |
68297 |
0.14 |
chr12_29532556_29532742 | 3.25 |
Myt1l |
myelin transcription factor 1-like |
736 |
0.63 |
chr11_97842036_97842206 | 3.24 |
B230217C12Rik |
RIKEN cDNA B230217C12 gene |
802 |
0.44 |
chr9_43747992_43748143 | 3.24 |
Gm30015 |
predicted gene, 30015 |
1967 |
0.26 |
chr13_44946654_44947258 | 3.21 |
Dtnbp1 |
dystrobrevin binding protein 1 |
188 |
0.96 |
chr7_144898015_144898977 | 3.21 |
Gm26793 |
predicted gene, 26793 |
1035 |
0.34 |
chr5_110518184_110518629 | 3.17 |
A630023P12Rik |
RIKEN cDNA A630023P12 gene |
2689 |
0.21 |
chr1_64116857_64117480 | 3.17 |
Klf7 |
Kruppel-like factor 7 (ubiquitous) |
4314 |
0.23 |
chr4_150651111_150652374 | 3.15 |
Slc45a1 |
solute carrier family 45, member 1 |
355 |
0.88 |
chr5_65130636_65132102 | 3.15 |
Klhl5 |
kelch-like 5 |
34 |
0.97 |
chr4_109342938_109343450 | 3.12 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
59 |
0.97 |
chr16_77594640_77595970 | 3.10 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
403 |
0.71 |
chr5_116589538_116590511 | 3.07 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1793 |
0.34 |
chr3_17785805_17785956 | 3.06 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
4041 |
0.22 |
chr14_118232996_118233241 | 3.04 |
Gm4675 |
predicted gene 4675 |
3114 |
0.17 |
chr19_58859577_58860158 | 3.03 |
Hspa12a |
heat shock protein 12A |
771 |
0.65 |
chr3_88206822_88208169 | 2.99 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr8_12399326_12400483 | 2.97 |
Gm25239 |
predicted gene, 25239 |
3501 |
0.16 |
chr5_19909654_19909839 | 2.95 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
1785 |
0.52 |
chr9_56634052_56634463 | 2.95 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
1371 |
0.44 |
chrX_7919510_7921219 | 2.89 |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
542 |
0.52 |
chr6_53880545_53881917 | 2.89 |
Gm22910 |
predicted gene, 22910 |
9083 |
0.21 |
chr7_62416059_62417205 | 2.86 |
Mkrn3 |
makorin, ring finger protein, 3 |
3507 |
0.2 |
chr12_53915674_53916197 | 2.85 |
1700060O08Rik |
RIKEN cDNA 1700060O08 gene |
163457 |
0.04 |
chr13_59673878_59674029 | 2.85 |
Golm1 |
golgi membrane protein 1 |
1819 |
0.19 |
chr1_194622071_194623282 | 2.85 |
Plxna2 |
plexin A2 |
2851 |
0.26 |
chrX_84076569_84077653 | 2.85 |
Dmd |
dystrophin, muscular dystrophy |
462 |
0.87 |
chr2_165042994_165043662 | 2.85 |
Ncoa5 |
nuclear receptor coactivator 5 |
8461 |
0.14 |
chr15_72807706_72808811 | 2.83 |
Peg13 |
paternally expressed 13 |
2066 |
0.4 |
chr8_54954519_54955779 | 2.83 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr12_99498193_99498610 | 2.82 |
Foxn3 |
forkhead box N3 |
48304 |
0.11 |
chr8_69180941_69181476 | 2.81 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
1022 |
0.49 |
chr1_42691569_42692627 | 2.81 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
995 |
0.42 |
chr10_29143400_29144848 | 2.80 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr3_119154592_119155474 | 2.78 |
Gm43410 |
predicted gene 43410 |
286789 |
0.01 |
chr5_30712882_30713845 | 2.78 |
Dpysl5 |
dihydropyrimidinase-like 5 |
1462 |
0.33 |
chr12_88724589_88725423 | 2.77 |
Nrxn3 |
neurexin III |
3 |
0.98 |
chr3_134241771_134242469 | 2.76 |
Gm26691 |
predicted gene, 26691 |
1479 |
0.22 |
chr9_43746633_43747189 | 2.75 |
Gm30015 |
predicted gene, 30015 |
811 |
0.54 |
chr17_85615752_85615903 | 2.74 |
Six3os1 |
SIX homeobox 3, opposite strand 1 |
419 |
0.76 |
chr15_75634671_75635033 | 2.74 |
Gm46519 |
predicted gene, 46519 |
1058 |
0.36 |
chr9_92930521_92931034 | 2.73 |
Gm28054 |
predicted gene 28054 |
34945 |
0.17 |
chr1_42700819_42701404 | 2.72 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
5343 |
0.14 |
chr11_87759834_87761999 | 2.72 |
Tspoap1 |
TSPO associated protein 1 |
329 |
0.75 |
chr4_151618882_151619088 | 2.71 |
4930589P08Rik |
RIKEN cDNA 4930589P08 gene |
242515 |
0.02 |
chr10_34299043_34301066 | 2.70 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr12_52700044_52701597 | 2.69 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
1437 |
0.46 |
chr9_41585694_41587243 | 2.66 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr1_155413773_155414214 | 2.66 |
Xpr1 |
xenotropic and polytropic retrovirus receptor 1 |
3336 |
0.31 |
chr6_86032237_86032468 | 2.64 |
Add2 |
adducin 2 (beta) |
3605 |
0.14 |
chr5_30106879_30107999 | 2.64 |
3110082J24Rik |
RIKEN cDNA 3110082J24 gene |
1353 |
0.28 |
chr1_6729327_6730832 | 2.61 |
St18 |
suppression of tumorigenicity 18 |
9 |
0.99 |
chr4_22481988_22482455 | 2.59 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
6145 |
0.18 |
chr14_100374663_100375528 | 2.59 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr9_105985279_105985546 | 2.56 |
Col6a4 |
collagen, type VI, alpha 4 |
12910 |
0.14 |
chr9_43070574_43070912 | 2.56 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
28111 |
0.16 |
chr7_141949754_141950818 | 2.55 |
Brsk2 |
BR serine/threonine kinase 2 |
200 |
0.83 |
chr13_71157717_71158937 | 2.54 |
Mir466f-4 |
microRNA 466f-4 |
51238 |
0.17 |
chr18_31445651_31446131 | 2.54 |
Syt4 |
synaptotagmin IV |
1515 |
0.34 |
chr11_35537773_35538027 | 2.53 |
Slit3 |
slit guidance ligand 3 |
6785 |
0.29 |
chr4_150283047_150283823 | 2.52 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
1623 |
0.32 |
chr16_77332032_77332723 | 2.51 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
2873 |
0.23 |
chr2_65932868_65933620 | 2.50 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
1379 |
0.47 |
chr4_110282527_110283235 | 2.50 |
Elavl4 |
ELAV like RNA binding protein 4 |
3735 |
0.36 |
chr1_88698575_88698781 | 2.49 |
Arl4c |
ADP-ribosylation factor-like 4C |
3198 |
0.22 |
chr19_47017205_47017356 | 2.49 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
2127 |
0.2 |
chr6_107534114_107534926 | 2.48 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
4752 |
0.26 |
chr5_26904124_26905425 | 2.48 |
Dpp6 |
dipeptidylpeptidase 6 |
79 |
0.98 |
chr2_105678552_105679922 | 2.48 |
Pax6 |
paired box 6 |
630 |
0.68 |
chr11_120239524_120240680 | 2.45 |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
3403 |
0.12 |
chr2_32741082_32742388 | 2.45 |
Sh2d3c |
SH2 domain containing 3C |
243 |
0.72 |
chr5_24454355_24456254 | 2.44 |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
2970 |
0.1 |
chr5_137733707_137734375 | 2.44 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
5677 |
0.09 |
chr9_4794566_4795419 | 2.44 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
527 |
0.88 |
chrX_105390628_105392456 | 2.43 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr19_47625250_47625629 | 2.42 |
Slk |
STE20-like kinase |
2209 |
0.21 |
chrX_103185752_103186844 | 2.42 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
342 |
0.83 |
chr13_83741336_83742027 | 2.41 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2818 |
0.16 |
chr1_62709496_62710533 | 2.41 |
Nrp2 |
neuropilin 2 |
6312 |
0.18 |
chr8_123410787_123412789 | 2.40 |
Tubb3 |
tubulin, beta 3 class III |
198 |
0.84 |
chr4_28300006_28300463 | 2.40 |
Gm11907 |
predicted gene 11907 |
53549 |
0.15 |
chr12_44438829_44439626 | 2.38 |
Nrcam |
neuronal cell adhesion molecule |
152 |
0.96 |
chr4_125493964_125494986 | 2.38 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
3775 |
0.23 |
chr4_9270926_9271667 | 2.37 |
Clvs1 |
clavesin 1 |
159 |
0.96 |
chr8_94995811_94996872 | 2.35 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
680 |
0.57 |
chr13_23269844_23270912 | 2.35 |
Vmn1r-ps135 |
vomeronasal 1 receptor, pseudogene 135 |
1498 |
0.19 |
chr3_31902373_31903967 | 2.35 |
Kcnmb2 |
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
467 |
0.88 |
chr10_28492781_28494073 | 2.33 |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
66724 |
0.13 |
chr2_4403551_4403975 | 2.33 |
Frmd4a |
FERM domain containing 4A |
2292 |
0.3 |
chr19_36534168_36535379 | 2.32 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19866 |
0.2 |
chr12_69907745_69908880 | 2.32 |
Atl1 |
atlastin GTPase 1 |
580 |
0.65 |
chr3_68573207_68574269 | 2.31 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr2_102448665_102449240 | 2.31 |
Fjx1 |
four jointed box 1 |
3547 |
0.29 |
chr1_99774621_99774914 | 2.30 |
Cntnap5b |
contactin associated protein-like 5B |
2002 |
0.38 |
chr11_32002849_32003000 | 2.29 |
Nsg2 |
neuron specific gene family member 2 |
2422 |
0.32 |
chr3_34377333_34377676 | 2.28 |
Gm38505 |
predicted gene, 38505 |
25792 |
0.17 |
chr19_32102301_32103300 | 2.27 |
Asah2 |
N-acylsphingosine amidohydrolase 2 |
324 |
0.92 |
chr2_131351541_131352096 | 2.27 |
Rnf24 |
ring finger protein 24 |
1044 |
0.45 |
chr19_37790493_37791115 | 2.27 |
Gm9067 |
predicted gene 9067 |
6538 |
0.23 |
chr11_105590925_105591452 | 2.26 |
Tanc2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
1197 |
0.51 |
chr2_180889143_180889758 | 2.26 |
Gm14342 |
predicted gene 14342 |
210 |
0.87 |
chr12_49386539_49386878 | 2.26 |
Gm43517 |
predicted gene 43517 |
1534 |
0.27 |
chr9_75681964_75682559 | 2.26 |
Scg3 |
secretogranin III |
1326 |
0.37 |
chr2_6881874_6882908 | 2.26 |
Gm13389 |
predicted gene 13389 |
1879 |
0.3 |
chr18_77560165_77560357 | 2.26 |
Rnf165 |
ring finger protein 165 |
4348 |
0.26 |
chr3_17790851_17791260 | 2.26 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1098 |
0.49 |
chr3_39219846_39220607 | 2.25 |
Gm43008 |
predicted gene 43008 |
2380 |
0.41 |
chr3_28265481_28265639 | 2.24 |
Tnik |
TRAF2 and NCK interacting kinase |
1917 |
0.36 |
chr17_91085493_91086001 | 2.24 |
Gm47307 |
predicted gene, 47307 |
2659 |
0.21 |
chr4_83284107_83285357 | 2.24 |
Ttc39b |
tetratricopeptide repeat domain 39B |
437 |
0.75 |
chr2_18315510_18316536 | 2.23 |
Dnajc1 |
DnaJ heat shock protein family (Hsp40) member C1 |
5765 |
0.22 |
chr13_44841435_44841934 | 2.23 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
901 |
0.61 |
chr4_116405618_116406369 | 2.23 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
7 |
0.98 |
chr3_88530048_88530199 | 2.23 |
Mex3a |
mex3 RNA binding family member A |
2272 |
0.12 |
chr17_91092075_91093120 | 2.23 |
Nrxn1 |
neurexin I |
136 |
0.95 |
chr8_31915784_31916390 | 2.22 |
Nrg1 |
neuregulin 1 |
1563 |
0.42 |
chr8_64690831_64691226 | 2.22 |
Cpe |
carboxypeptidase E |
2026 |
0.3 |
chr6_134886811_134888239 | 2.21 |
Gpr19 |
G protein-coupled receptor 19 |
243 |
0.87 |
chr5_111424407_111425623 | 2.21 |
Gm43119 |
predicted gene 43119 |
1426 |
0.38 |
chr1_77502484_77503419 | 2.20 |
Mir6352 |
microRNA 6352 |
6183 |
0.2 |
chr4_91398983_91399134 | 2.20 |
Elavl2 |
ELAV like RNA binding protein 1 |
918 |
0.62 |
chr1_66386919_66387899 | 2.19 |
Map2 |
microtubule-associated protein 2 |
398 |
0.87 |
chr9_16499021_16499195 | 2.19 |
Fat3 |
FAT atypical cadherin 3 |
2177 |
0.44 |
chr19_4758474_4759201 | 2.17 |
Rbm4b |
RNA binding motif protein 4B |
1932 |
0.18 |
chr7_51621596_51622924 | 2.17 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
39 |
0.98 |
chr16_38548429_38548616 | 2.17 |
Poglut1 |
protein O-glucosyltransferase 1 |
1700 |
0.26 |
chr5_19907724_19909563 | 2.16 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
682 |
0.82 |
chr18_43391464_43391742 | 2.16 |
Dpysl3 |
dihydropyrimidinase-like 3 |
1774 |
0.41 |
chr3_4799014_4799414 | 2.16 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
279 |
0.93 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.6 | 6.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.4 | 4.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.4 | 4.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.2 | 9.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.2 | 4.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.0 | 3.0 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.0 | 3.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.0 | 7.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.9 | 2.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.8 | 3.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.8 | 3.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.8 | 0.8 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.8 | 3.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.8 | 6.2 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.8 | 3.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.7 | 5.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.7 | 2.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.7 | 4.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.7 | 7.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.7 | 6.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.7 | 7.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 2.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.7 | 3.3 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.7 | 3.3 | GO:0021764 | amygdala development(GO:0021764) |
0.6 | 3.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 3.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.6 | 3.1 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.6 | 3.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 1.7 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.6 | 1.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.6 | 2.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.6 | 5.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.6 | 1.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.5 | 1.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 1.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.5 | 2.1 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.5 | 2.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 1.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 1.0 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.5 | 1.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.5 | 1.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.5 | 1.4 | GO:0060594 | mammary gland specification(GO:0060594) |
0.5 | 1.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.5 | 1.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 2.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 3.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.4 | 1.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 6.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.4 | 0.8 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.4 | 0.8 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.4 | 0.8 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.4 | 1.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 2.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 1.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 0.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 2.0 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.4 | 5.1 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.4 | 1.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.4 | 1.6 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 2.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 6.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 0.8 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 0.8 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.4 | 1.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 3.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.4 | 1.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 1.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 1.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.4 | 3.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 1.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 0.7 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.3 | 2.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 0.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 0.6 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.3 | 1.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 0.6 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.3 | 0.9 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.3 | 0.9 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 0.9 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 0.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.3 | 1.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 1.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 1.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 0.6 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 0.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.3 | 0.3 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.3 | 1.1 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.3 | 0.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 0.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 0.8 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.3 | 0.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 1.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 1.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 2.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 1.3 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 0.8 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.3 | 1.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.2 | 0.7 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 1.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 1.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 0.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 1.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 5.3 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 0.9 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 4.3 | GO:0060384 | innervation(GO:0060384) |
0.2 | 7.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 0.7 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 2.4 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.4 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.2 | 1.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.6 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 0.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 1.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.2 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 4.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.6 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 1.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 2.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 1.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 1.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.8 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 1.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 0.9 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.7 | GO:1902966 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.2 | 0.2 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.2 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.5 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 0.9 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 0.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.3 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.5 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 6.5 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 8.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.3 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 0.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 0.3 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.2 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.5 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 0.8 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 1.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.7 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 2.4 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.3 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.1 | 0.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 1.0 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 1.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.9 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.4 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 1.1 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.5 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.3 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.9 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.4 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.1 | 0.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.1 | 2.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 1.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.4 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.1 | 0.2 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.4 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 0.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.5 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 2.1 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.1 | 0.6 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 1.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.1 | 1.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 1.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 1.5 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.2 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.1 | 0.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 1.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 2.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 1.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.6 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 2.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 2.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.5 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.2 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.6 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 1.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 1.0 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 1.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 1.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.6 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.3 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.8 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 1.7 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 6.8 | GO:0007612 | learning(GO:0007612) |
0.1 | 1.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.8 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 1.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 7.1 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.1 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 1.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.2 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.3 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 0.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 4.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.2 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.2 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.1 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.1 | GO:0035090 | maintenance of cell polarity(GO:0030011) maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.2 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0042161 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.8 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 1.0 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.1 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.4 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 3.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 1.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 1.5 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.1 | 0.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.5 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.2 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.1 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.1 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.1 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.1 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.8 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.2 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.6 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.1 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.1 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.2 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.4 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.2 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.0 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.0 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 2.8 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
0.0 | 0.2 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.0 | 1.9 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.0 | 1.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.7 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.5 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.2 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.6 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
0.0 | 0.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.2 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.4 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.0 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.0 | 2.0 | GO:0099531 | neurotransmitter secretion(GO:0007269) presynaptic process involved in chemical synaptic transmission(GO:0099531) signal release from synapse(GO:0099643) |
0.0 | 0.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.0 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.1 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.0 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.0 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.0 | 0.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.4 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.0 | 0.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.0 | 0.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.0 | 0.2 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.2 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 2.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.2 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.0 | 1.0 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.0 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.2 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.0 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 1.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.3 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.0 | 0.1 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.0 | 0.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.0 | 0.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.3 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.4 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.1 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:0003133 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.0 | 0.0 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.2 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 2.2 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.1 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.0 | 0.4 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.0 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.5 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.0 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.4 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.2 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.0 | 0.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 1.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.7 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.1 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.0 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) |
0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.0 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.0 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.0 | GO:0061511 | centriole elongation(GO:0061511) |
0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.1 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.3 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.0 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.0 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 0.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.2 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 1.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.0 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.0 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.0 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.7 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.0 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) |
0.0 | 0.1 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.0 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0046794 | transport of virus(GO:0046794) |
0.0 | 0.0 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.0 | 0.2 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.1 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.1 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.0 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.0 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.0 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.0 | 0.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.0 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.0 | 0.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.0 | GO:0032824 | peptidoglycan metabolic process(GO:0000270) natural killer cell differentiation involved in immune response(GO:0002325) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.0 | 0.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.0 | 0.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.0 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.7 | 2.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.7 | 4.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 2.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 2.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.5 | 4.8 | GO:0005883 | neurofilament(GO:0005883) |
0.5 | 6.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 3.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.5 | 3.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 4.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 14.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 1.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 10.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 1.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 2.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 13.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 5.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 1.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 2.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 0.9 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 2.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 12.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 5.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 2.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 1.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 2.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 1.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 2.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 3.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 2.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 3.1 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 8.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 1.7 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 11.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 1.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 1.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 14.7 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 2.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 3.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 0.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 1.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 6.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 11.7 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.8 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.6 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 14.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 2.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.6 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 1.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.5 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.1 | 19.9 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 1.2 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.1 | GO:0042827 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.1 | 0.4 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.2 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 1.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.3 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.0 | 1.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 1.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 1.0 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.3 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.4 | GO:0097346 | Ino80 complex(GO:0031011) INO80-type complex(GO:0097346) |
0.0 | 0.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.9 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.3 | GO:0036452 | ESCRT III complex(GO:0000815) ESCRT complex(GO:0036452) |
0.0 | 0.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.0 | 0.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.9 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 3.5 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 1.3 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.0 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.2 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 1.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 15.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.4 | 7.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.2 | 3.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.2 | 2.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.0 | 2.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.9 | 2.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 4.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 2.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.7 | 2.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.7 | 2.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 2.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.6 | 1.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 3.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 2.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.5 | 3.0 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.5 | 2.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.5 | 3.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 5.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.4 | 3.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 1.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 2.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.4 | 1.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 0.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.4 | 1.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 1.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.4 | 1.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.4 | 4.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 2.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 1.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 5.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 1.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 2.2 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 1.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.3 | 1.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 4.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 1.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 2.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 5.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 0.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 1.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 0.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 3.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 6.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 1.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 2.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 1.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.3 | 2.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 1.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 1.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 1.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 5.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 1.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 3.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 3.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 2.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 1.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 3.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 3.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 2.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 3.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 10.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 1.8 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 2.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 1.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 2.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 1.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.5 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.9 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 1.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 4.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 1.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 1.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.6 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 2.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 2.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 1.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 1.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 1.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 1.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 2.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 1.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 1.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 3.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 1.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 14.0 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 0.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.1 | GO:0016149 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 1.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 2.2 | GO:0051922 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.1 | 0.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 1.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 2.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 2.4 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 3.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 1.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.5 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 4.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 11.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.1 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 1.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.7 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.0 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.2 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
0.0 | 0.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.0 | 2.5 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 1.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.5 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 1.2 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.2 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.0 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.3 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.0 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 7.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 2.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 2.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 3.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 5.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 7.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 1.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 1.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 5.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 4.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 2.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 2.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 1.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 5.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 4.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.4 | 5.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 1.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 5.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 3.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 3.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 7.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 6.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 2.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 3.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 4.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 4.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 4.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 3.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 3.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 3.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 1.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 5.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.1 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 0.7 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 0.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 4.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 4.0 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.7 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 2.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 1.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.4 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.6 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 1.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.3 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 0.1 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 5.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 3.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.0 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.6 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |